Latest TFFP reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. TFF Pharmaceuticals
  4. Financial Statements
  5. Balance Sheet
TFF Pharmaceuticals logo
TFF Pharmaceuticals TFFP
$ 1.78 0.0%
mail-toReport an Error

TFF Pharmaceuticals Balance Sheet 2011-2024 | TFFP

Annual Balance Sheet TFF Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

 -5.36 M -16.4 M - -35.3 M -28.1 M -10.3 M - - - - - - -

Long Term Debt

 31.7 K 110 K - - - - - - - - - - -

Long Term Debt Current

 83.5 K 80.6 K - - - - - - - - - - -

Total Non Current Liabilities

 - - - - 1.13 M - - - - - - - -

Total Current Liabilities

 2.43 M 1.13 M 1.96 M - 411 K - - - - - - - -

Total Liabilities

 2.46 M 1.24 M 1.96 M 1.32 M 1.54 M 1.16 M 1.83 K - - - - - -

Deferred Revenue

 101 K 126 K - 24.3 K - - - - - - - - -

Retained Earnings

 -118 M -97.1 M -65.3 M -34.3 M -15.7 M -3.84 M -1.83 K - - - - - -

Total Assets

 12 M 24.1 M 40.7 M 38.7 M 29.2 M 10.4 M - - - - - - -

Cash and Cash Equivalents

 5.48 M 16.6 M 33.8 M 35.3 M 28.1 M 10.3 M - - - - - - -

Book Value

 9.57 M 22.9 M 38.7 M 37.3 M 27.6 M 9.24 M -1.83 K - - - - - -

Total Shareholders Equity

 9.57 M 22.9 M 38.7 M 37.3 M 27.6 M -3.24 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet TFF Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

 10.9 K 31.7 K 52.2 K 72.3 K 91.5 K 110 K 128 K 146 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

 3.88 M 2.46 M 1.19 M 1.29 M 1.67 M 1.24 M 2.2 M 3.97 M 2.2 M 1.96 M 1.56 M 1.53 M 1.82 M 1.32 M 1.32 M 1.32 M 1.32 M 1.54 M 1.54 M 1.54 M 1.54 M 1.16 M 1.16 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

 140 K 101 K 76 K - - 126 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

 -124 M -118 M -114 M -109 M -104 M -97.1 M -89.7 M -82.4 M -73.7 M -65.3 M -55.3 M -46.6 M -41.9 M -34.3 M -34.3 M -34.3 M -34.3 M -15.7 M -15.7 M -15.7 M -15.7 M -3.84 M -3.84 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

 9.19 M 12 M 14.9 M 13.6 M 18.2 M 24.1 M 20.2 M 27.9 M 33.8 M 40.7 M 49.3 M 57.2 M 61.4 M 38.7 M 38.7 M 38.7 M 38.7 M 29.2 M 29.2 M - - 10.4 M 10.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

 3.21 M 5.48 M 9.73 M 7.66 M 12.2 M 16.6 M 13.1 M 20.9 M 26.4 M 33.8 M 44.7 M 52.1 M 58.1 M 35.3 M 35.3 M 35.3 M 35.3 M 28.1 M 28.1 M 28.1 M 28.1 M 10.3 M 10.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

 5.3 M 9.57 M 13.7 M 12.3 M 16.5 M 22.9 M 18 M 23.9 M 31.6 M 38.7 M 47.7 M 55.6 M 59.5 M 37.3 M 37.3 M 37.3 M 37.3 M 27.6 M 27.6 M -1.54 M -1.54 M 9.24 M 9.24 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

 5.3 M 9.57 M 13.7 M 12.3 M 16.5 M 22.9 M 18 M 23.9 M 31.6 M 38.7 M 47.7 M 55.6 M 59.5 M 37.3 M 37.3 M 37.3 M 37.3 M 27.6 M 27.6 M 27.6 M 27.6 M -3.24 M -3.24 M -1.5 M -268 K -1.83 K - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency